Phase II study of Velcade [bortezomib] in Waldenstrom's macroglobulinemia
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2007
At a glance
- Drugs Bortezomib (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed.
- 07 Nov 2005 New trial record.